Clinical Trial

Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass

Study acronym: VCAB-2
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
To assess safety and feasibility of a coronary bypass created with Vascudyne Acellular Tissue Engineered Vessel (ATEV) with External Support Structure (ESS) in patients requiring multi vessel coronary artery bypass grafting (CABG).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-17.
Trial Details
NCT Number NCT07078370
Lead Sponsor Vascudyne, Inc.
Collaborators: KCRI
Conditions Coronary Artery Disease, Multi Vessel Coronary Artery Disease
Enrollment 20 participants
Start Date 2025-08-28
Primary Completion 2027-03-30 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-29